Skip to main content
How Ketamine Therapy Works

How ketamine therapy is believed to work.

Ketamine has a mechanism of action distinct from traditional antidepressants. This page explains what current research suggests about how it may help — and where the evidence is still evolving.

Written by: Editorial Team, Sarasota Ketamine TherapyMedically reviewed by: Medical Reviewer, Sarasota Ketamine TherapyLast reviewed:

A different mechanism than traditional antidepressants

Most first-line antidepressants — SSRIs and SNRIs — work primarily on serotonin and norepinephrine systems. They typically take four to eight weeks to produce meaningful improvement, and a meaningful fraction of patients do not experience adequate relief with them. Ketamine appears to work through a different pathway, which is part of why it has drawn clinical and research interest in psychiatric care.

Ketamine is an N-methyl-D-aspartate (NMDA) receptor antagonist. In simplified terms, it briefly modulates the brain's primary excitatory neurotransmitter system — glutamate. The clinical effect that researchers have focused on is a downstream increase in synaptic connectivity, often referred to as neuroplasticity.

What research suggests about neuroplasticity

Studies in humans and animal models suggest that ketamine can promote the growth of new dendritic spines, the tiny connections between neurons that support learning and mood regulation. Chronic depression and chronic stress have been associated with the opposite: a loss of synaptic connections in certain brain regions. Research suggests ketamine may help re-establish some of these connections, opening what clinicians sometimes describe as a "window of plasticity" during which new patterns can more easily form.

Importantly, plasticity is a capacity, not a change in itself. What patients build during that window — through therapy, integration coaching, journaling, sleep, exercise, and connection — is a major part of why sustained results tend to come from a structured program rather than a single dose.

Onset and durability of effects

Onset

One of the clinically striking observations about ketamine is that some patients report improvement in mood within hours to days of a session, rather than the weeks required by traditional antidepressants. Individual response varies, and not everyone experiences a rapid effect.

Durability

A single session's effects are typically time-limited. Durable improvement tends to follow a structured course of sessions (an "induction phase"), paired with ongoing psychological work. Maintenance sessions, when appropriate, help sustain progress. The evidence base for optimal maintenance schedules is still maturing; clinical judgment plays a major role.

How dosing and route of administration matter

Ketamine can be delivered by several routes: intravenous (IV) infusion, intramuscular (IM) injection, intranasal spray (Spravato/esketamine, in a certified in-office setting), and oral formulations. Each has a different absorption profile, onset, duration, and typical dose range.

Low-dose oral ketamine — the format used in our program — has a slower onset and produces a milder subjective experience than IV or IM ketamine. That gentler profile is part of why it is well-suited to medically supervised at-home protocols, when patients are appropriately screened. Higher-intensity formats generally belong in clinical settings under direct supervision.

Why integration matters as much as the medicine

Even in the best-case scenario, ketamine is a tool. The work that translates a session into a lasting shift usually happens between sessions — through journaling, structured integration coaching, changes to sleep and movement, and, where appropriate, ongoing psychotherapy. Programs that skip integration tend to treat ketamine as a symptom reliever rather than a catalyst; that misses much of what makes the format useful.

Where the evidence is still evolving

Ketamine's use in psychiatric care is off-label in the United States (other than esketamine, which is FDA-approved for certain indications). Research is active and ongoing. Areas where evidence continues to develop include long-term outcomes, optimal maintenance schedules, ideal dosing for specific conditions, and how ketamine best combines with psychotherapy modalities.

A responsible clinical program is transparent about these open questions, treats each patient's response as clinical data, and adjusts the plan accordingly.

What this means for you

If you are considering ketamine therapy, the practical takeaway is this: the "mechanism" is not magic, and the medicine is not the whole treatment. A well-run program pairs the biology with the psychology — careful screening, low-dose supervised protocols, structured integration, and honest expectation-setting.

Whether it is right for you is a clinical determination that requires a comprehensive medical evaluation with a licensed provider.

Wondering if this is right for you?

Book a free, no-obligation discovery call. We'll answer your questions and see whether a medical evaluation is the right next step.